Post COVID-19 syndrome with impairment of flow-mediated epicardial vasodilation and flow reserve

Amanda Verma1,2, Tarun Ramayya2, Anand Upadhyaya1

  • 1Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.

Insights

Post-acute sequelae of COVID-19 cardiovascular syndrome (PASC-CVS) may involve impaired epicardial vasodilation. This study found reduced coronary vasodilator capacity in PASC-CVS patients, linked to increased resting blood flow, particularly in women.

Area of Science:

  • Cardiovascular Physiology
  • Infectious Diseases
  • Medical Imaging

Background:

  • Post-acute sequelae of COVID-19 cardiovascular syndrome (PASC-CVS) can manifest with various cardiovascular symptoms.
  • The underlying mechanisms of PASC-CVS, particularly concerning coronary circulation, require further elucidation.
  • Assessing coronary circulatory function is crucial for understanding long-term COVID-19 impacts.

Purpose of the Study:

  • To investigate potential alterations in coronary circulatory function in individuals with PASC-CVS.
  • To evaluate the association between PASC-CVS and myocardial blood flow (MBF) dynamics.
  • To determine if PASC-CVS impacts global myocardial flow reserve (MFR) and epicardial vasodilation.

Main Methods:

  • Myocardial blood flow (MBF) and global myocardial flow reserve (MFR) were assessed using 13N-ammonia PET/CT.
  • Measurements included resting and hyperemic MBF, and the longitudinal MBF gradient, in PASC-CVS patients and healthy controls.
  • Participants were individuals with PASC-CVS without prior cardiovascular risk factors and age-matched healthy controls.

Main Results:

  • Patients with PASC-CVS exhibited significantly higher resting MBF compared to healthy controls.
  • No significant difference in hyperemic MBF was observed between the PASC-CVS and control groups.
  • PASC-CVS patients showed significantly lower MFR and a notable Δ longitudinal MBF gradient, indicating impaired vasodilation.

Conclusions:

  • PASC-CVS may be associated with impaired flow-mediated epicardial vasodilation.
  • Reductions in coronary vasodilator capacity in PASC-CVS appear primarily linked to elevated resting blood flow.
  • Further research is warranted to explore these findings, especially concerning female patients.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
36
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
28
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
29